Agilent gets FDA approval for PD-L1 IHC 22C3 pharmDx
Agilent gets FDA approval for PD-L1 IHC 22C3 pharmDx is drawing significant interest across the industry.
Agilent (A) “announced that the U.S. Food and Drug Administration has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved comp...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- NVIDIA Adds a Dozen Games to its Expansive 4,500+ Library of GeForce NOW Titles
- Credo Is No Longer Just A Cable Story - Earnings Preview
- Cooper says he'll work to lower healthcare costs if elected
- New Work Requirements Begin for SNAP Recipients
Source: Original →